IL13 and allergic disease: On the other hand, the reQTL for IL13 in neonatal PHA-stimulated T cells appeared to share causal variants with allergic disease and asthma, suggesting that this reQTL may affect allergic disease risk via mechanisms that do involve T cell activation and interleukin 13 (IL-13).